215 related articles for article (PubMed ID: 4137165)
1. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.
Lindahl T; Klein G; Reedman BM; Johansson B; Singh S
Int J Cancer; 1974 Jun; 13(6):764-72. PubMed ID: 4137165
[No Abstract] [Full Text] [Related]
2. Demonstration of Epstein-Barr virus in malignant non-Hodgkin's lymphomas.
Wutzler P; Färber I; Sauerbrei A; Helbig B; Wutke K; Rüdiger KD; Scheibner K; Brichàcek B; Vonka V
Oncology; 1986; 43(4):224-9. PubMed ID: 2425318
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies.
Reedman BM; Klein G; Pope JH; Walters MK; Hilgers J; Singh S; Johansson B
Int J Cancer; 1974 Jun; 13(6):755-63. PubMed ID: 4136722
[No Abstract] [Full Text] [Related]
4. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
Bachmann AE; Giraudo Conesa LC; Braun M
Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
[No Abstract] [Full Text] [Related]
5. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda.
Olweny CL; Atine I; Kaddu-Mukasa A; Owor R; Andersson-Anvret M; Klein G; Henle W; de-Thé G
J Natl Cancer Inst; 1977 May; 58(5):1191-6. PubMed ID: 192894
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
Yang CS; Hewetson JF
Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
[No Abstract] [Full Text] [Related]
7. EBV infections in Brazil. I. Occurrence in normal persons, in lymphomas and in leukemias.
Carvalho RP; Evans AS; Frost P; Dalldorf G; Camargo ME; Jamra M
Int J Cancer; 1973 Jan; 11(1):191-201. PubMed ID: 4364322
[No Abstract] [Full Text] [Related]
8. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-related serology in Hodgkin's disease.
Henle W; Henle G
Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
[No Abstract] [Full Text] [Related]
10. [Malignant lymphoma which contained EBV DNA and lacked EBNA2 antibody].
Shimakage M; Hirai K; Ikegami N; Matsubuchi T; Kawagoe H
Rinsho Ketsueki; 1989 Jul; 30(7):1091-2. PubMed ID: 2554014
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-induced malignant lymphoma in a white-lipped marmoset.
Sundar SK; Levine PH; Ablashi DV; Leiseca SA; Armstrong GR; Cicmanec JL; Parker GA; Nonoyama M
Int J Cancer; 1981 Jan; 27(1):107-11. PubMed ID: 6265385
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNA.
Szigeti R; Saemundsen AK; Synnerholm AC; Henle G; Henle W; Klein G
Cancer Res; 1983 May; 43(5):2273-6. PubMed ID: 6299543
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-immune complexes in postmortem kidneys from African patients with Burkitt's lymphoma and American patients with and without lymphoma.
Sutherland JC; Olweny CL; Levine PH; Mardiney MR
J Natl Cancer Inst; 1978 May; 60(5):941-6. PubMed ID: 205665
[No Abstract] [Full Text] [Related]
15. Persistent active Epstein-Barr virus infection and atypical lymphoproliferation. Report of two cases.
Krueger GR; Papadakis T; Schaefer HJ
Am J Surg Pathol; 1987 Dec; 11(12):972-81. PubMed ID: 2825551
[TBL] [Abstract][Full Text] [Related]
16. [Antibodies against the Epstein-Barr Virus nuclear-antigen in children with malignant disease (author's transl)].
Lubec G; Jürgenssen O
Osterr Z Onkol; 1976; 3(4):96-9. PubMed ID: 189271
[TBL] [Abstract][Full Text] [Related]
17. Detection of Epstein-Barr virus DNA in American Burkitt's lymphoma.
Ziegler JL; AnderssonM ; Klein G; Henle W
Int J Cancer; 1976 Jun; 17(6):701-6. PubMed ID: 181331
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
Reedman BM; Hilgers J; Hilgers F; Klein G
Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
[TBL] [Abstract][Full Text] [Related]
19. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.
Clements GB; Klein G; Povey S
Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210
[TBL] [Abstract][Full Text] [Related]
20. Detection of primary Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease receiving immunoglobulin prophylaxis.
Okano M; Bashir RM; Davis JR; Purtilo DT
Am J Hematol; 1991 Apr; 36(4):294-6. PubMed ID: 1849350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
